The use of three murine genetic models of Alzheimer’s disease reveals efficacy of 4′,5,7-trihydroxyisoflavone in alleviating cognitive deficits and reducing levels of amyloid-beta and hyperphosphorylated tau protein
The use of three murine genetic models of Alzheimer’s disease reveals efficacy of 4′,5,7-trihydroxyisoflavone in alleviating cognitive deficits and reducing levels of amyloid-beta and hyperphosphorylated tau protein
Aneta Szulc, Lidia Gaffke, Karolina Pierzynowska, Magdalena Podlacha et al.
Journal
Laboratory Animal Research
Topics
Alzheimer's disease research and treatments
article
The use of three murine genetic models of Alzheimer’s disease reveals efficacy of 4′,5,7-trihydroxyisoflavone in alleviating cognitive deficits and reducing levels of amyloid-beta and hyperphosphorylated tau protein